{
  "id": 16986691,
  "title": "SK Bioscience Joins U.S.-Backed Ebola Project",
  "url": "https://urgent.news/2026/10/29/sk-bioscience-joins-u-s-backed-ebola-project",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-29T01:24:52.000Z",
  "source": {
    "name": "BusinessKorea",
    "slug": "businesskorea",
    "url": "https://www.businesskorea.co.kr/news/articleView.html?idxno=279921"
  },
  "original_language": "en",
  "account": null,
  "summary": "SK Bioscience has joined a U.S.-backed Ebola vaccine project that has received up to $99 million in funding from the Biomedical Advanced Research and Development Authority (BARDA) under the Department of Health and Human Services. The project, led by the International AIDS Vaccine Initiative (IAVI) and Hilleman Laboratories, aims to develop a vaccine that can rapidly induce immunity with a single dose for the Bundibugyo virus, which has been spreading mainly in the Democratic Republic of the Congo. SK Bioscience will be responsible for process scale-up and mass production of the vaccine, utilizing its German subsidiary IDT Biologika for drug product process from aseptic filling through final product manufacturing.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}